DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, announced that the latest clinical data on its newest diagnostic product, the AspirinWorks® Test Kit, will be released at the XXIst Congress of the International Society on Thrombosis and Hemostasis (ISTH) and the 53rd Annual Scientific and Standardization Committee (SSC) Meeting to be held in Geneva, Switzerland from July 6-12, 2007. This meeting is recognized as one of the most important international events relating to thrombosis and abnormalities of hemostasis and vascular biology.
